• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

司库奇尤单抗导致一名诊断为银屑病和类风湿关节炎患者的药物相关性颌骨坏死。

Secukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritis.

作者信息

Hauer Lukas, Moztarzadeh Omid, Baghalipour Nasimeh, Gencur Jiri

机构信息

Department of Stomatology, University Hospital Pilsen, Faculty of Medicine in Pilsen, Charles University, Pilsen, 32300, Czech Republic.

Department of Anatomy, Faculty of Medicine in Pilsen, Charles University, Pilsen, 32300, Czech Republic.

出版信息

Psoriasis (Auckl). 2024 Sep 23;14:115-120. doi: 10.2147/PTT.S490982. eCollection 2024.

DOI:10.2147/PTT.S490982
PMID:39347517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11430215/
Abstract

The use of antiangiogenic and antiresorptive medications, particularly in patients with cancer or osteoporosis, can lead to osteonecrosis of the jaw following tooth extraction, trauma or arising spontaneously- A condition known as medication-related osteonecrosis of the jaw (MRONJ). In this article, we present a unique case of MRONJ in a patient with no history of antiresorptive or antiangiogenic drug use, who was instead taking the anti-interleukin 17-A (Secukinumab) medication for severe psoriasis. This association has not been previously reported in the literature.

摘要

抗血管生成和抗吸收药物的使用,尤其是在癌症或骨质疏松症患者中,在拔牙、外伤后或自发发生时可导致颌骨坏死——一种称为药物相关性颌骨坏死(MRONJ)的病症。在本文中,我们报告了一例独特的MRONJ病例,该患者无抗吸收或抗血管生成药物使用史,而是正在服用抗白细胞介素17 - A(司库奇尤单抗)药物治疗严重银屑病。这种关联此前尚未见文献报道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ee/11430215/515108ac352b/PTT-14-115-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ee/11430215/1c27466c835b/PTT-14-115-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ee/11430215/515108ac352b/PTT-14-115-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ee/11430215/1c27466c835b/PTT-14-115-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ee/11430215/515108ac352b/PTT-14-115-g0002.jpg

相似文献

1
Secukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritis.司库奇尤单抗导致一名诊断为银屑病和类风湿关节炎患者的药物相关性颌骨坏死。
Psoriasis (Auckl). 2024 Sep 23;14:115-120. doi: 10.2147/PTT.S490982. eCollection 2024.
2
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
3
Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.药物相关性颌骨坏死:双膦酸盐治疗患者与抗吸收-抗血管生成药物治疗患者的风险因素
Minerva Stomatol. 2017 Aug;66(4):135-140. doi: 10.23736/S0026-4970.17.04056-0. Epub 2017 May 10.
4
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
5
Emerging antiresorptive medications and their potential implications for dental surgeries.新兴的抗吸收药物及其对牙科手术的潜在影响。
J Am Dent Assoc. 2022 Jul;153(7):649-658. doi: 10.1016/j.adaj.2021.12.008. Epub 2022 Mar 8.
6
Medication-related osteonecrosis of the jaw: Case series and literature review.药物相关性颌骨坏死:病例系列与文献综述
Clin Case Rep. 2024 Apr 20;12(4):e8788. doi: 10.1002/ccr3.8788. eCollection 2024 Apr.
7
Guselkumab: A new etiological factor of medication related osteonecrosis of the jaw (MRONJ)? A case report.古塞单抗:药物相关性颌骨坏死(MRONJ)的新病因学因素?一例报告。
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(5S1):101985. doi: 10.1016/j.jormas.2024.101985. Epub 2024 Jul 25.
8
Osteonecrosis of the Jaw in the Absence of Antiresorptive or Antiangiogenic Exposure: A Series of 6 Cases.无抗吸收或抗血管生成药物暴露情况下的颌骨骨坏死:6例病例系列
J Oral Maxillofac Surg. 2017 Jan;75(1):129-142. doi: 10.1016/j.joms.2016.07.019. Epub 2016 Jul 30.
9
Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?抗血管生成药物治疗患者药物相关性颌骨坏死(MRONJ)的系统评价:手术还是保守治疗?
Br J Oral Maxillofac Surg. 2022 Feb;60(2):e216-e230. doi: 10.1016/j.bjoms.2021.03.006. Epub 2021 Mar 24.
10
Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.不同原发性癌症及药物治疗相关颌骨骨坏死(MRONJ)的影像学评估
Cureus. 2023 Aug 1;15(8):e42830. doi: 10.7759/cureus.42830. eCollection 2023 Aug.

引用本文的文献

1
Chronic Hyperplastic Candidiasis-An Adverse Event of Secukinumab in the Oral Cavity: A Case Report and Literature Review.慢性增生性念珠菌病——司库奇尤单抗在口腔中的不良事件:一例报告及文献综述
Diseases. 2025 Aug 3;13(8):243. doi: 10.3390/diseases13080243.
2
Comprehensive Review of Prevention and Management Strategies for Medication-related Osteonecrosis of the Jaw (MRONJ).颌骨药物性骨坏死(MRONJ)预防与管理策略的综合综述
Oral Health Prev Dent. 2025 Aug 5;23:403-417. doi: 10.3290/j.ohpd.c_2169.
3
Identified Medications Causing Medication-Related Osteonecrosis of the Jaw: A Literature Review.

本文引用的文献

1
Guselkumab: A new etiological factor of medication related osteonecrosis of the jaw (MRONJ)? A case report.古塞单抗:药物相关性颌骨坏死(MRONJ)的新病因学因素?一例报告。
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(5S1):101985. doi: 10.1016/j.jormas.2024.101985. Epub 2024 Jul 25.
2
Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania.司库奇尤单抗和依奇珠单抗治疗中度至重度斑块状银屑病患者的有效性和药物留存率:来自罗马尼亚布加勒斯特的真实世界数据
Psoriasis (Auckl). 2024 Jun 25;14:79-86. doi: 10.2147/PTT.S456393. eCollection 2024.
3
已确定的导致药物相关性颌骨坏死的药物:文献综述
Cureus. 2025 Jun 24;17(6):e86645. doi: 10.7759/cureus.86645. eCollection 2025 Jun.
Maxillary Bone Necrosis in Post-COVID-19 Patients: Possibility of Medication-Related Osteonecrosis of Jaws (MRONJ) Induced by Tocilizumab.
新冠后患者的上颌骨坏死:托珠单抗诱导的药物相关性颌骨坏死(MRONJ)的可能性。
J Craniofac Surg. 2024;35(5):e454-e457. doi: 10.1097/SCS.0000000000010184. Epub 2024 May 6.
4
Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea.司库奇尤单抗在中度至重度斑块状银屑病成年患者中的真实世界安全性和有效性:韩国上市后监测结果
Ther Adv Chronic Dis. 2024 Feb 26;15:20406223241230180. doi: 10.1177/20406223241230180. eCollection 2024.
5
Severe Xerostomia Induced by Multiple Systemic Diseases in a Patient with Psoriasis Vulgaris: A Case Report and Literature Review.寻常型银屑病患者多种全身性疾病诱发的严重口干症:一例报告及文献综述
Int Med Case Rep J. 2024 Jan 31;17:77-88. doi: 10.2147/IMCRJ.S453097. eCollection 2024.
6
Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.药物相关性下颌骨坏死(MRONJ):发病机制假说和治疗策略的综述。
Arch Toxicol. 2024 Mar;98(3):689-708. doi: 10.1007/s00204-023-03653-7. Epub 2023 Dec 28.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药物治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2023 Jul 12;7(7):CD011535. doi: 10.1002/14651858.CD011535.pub6.
8
A Comparison of Clinical Characteristics in Overweight/Obese and Normal Weight Patients with Psoriasis Vulgaris: A Bicentric Retrospective Observational Study.寻常型银屑病超重/肥胖与正常体重患者的临床特征比较:一项双中心回顾性观察研究。
Clin Cosmet Investig Dermatol. 2023 May 30;16:1377-1385. doi: 10.2147/CCID.S411636. eCollection 2023.
9
Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis.服用抗吸收药物患者的拔牙管理:一项证据图谱综述与荟萃分析
J Clin Med. 2022 Dec 28;12(1):239. doi: 10.3390/jcm12010239.
10
Osimertinib: Another medication related to osteonecrosis of the jaws? A case report and literature review.奥希替尼:另一种与颌骨坏死相关的药物?一例病例报告及文献综述。
Front Pharmacol. 2022 Aug 10;13:947947. doi: 10.3389/fphar.2022.947947. eCollection 2022.